BIIB-3-21-19

BIIB – too early to catch it Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases. It has very strong fundamentals: Net Margin 43.8%, Return on Capital 138% and its relatively cheap Read more…

Login